Four-Bagger Biotech In One Day
549982
Acorda's shares zoomed up, but potential investors should be cautious.
461018
Within 50 years, biotech will suffuse everyday life just as computer technology does now -- so says Freeman Dyson.  It's not new, but the futurist describes his vision, from DIY genetic engineering for pigeon fanciers and schoolchildren to green industrial.
767559
Engineered E. coli proves efficient at churning out the biofuel.
74167
Nanoparticles allow researchers to initiate biochemical events at will.
181860
Platforms have the potential to develop multiple drugs for a company.
118359
The Fool interviews the CEO of a biotech with a specialized approach.
304071
Biogen releases its third-quarter financial results.
299610
Biotech crops are flourishing in the United States, but they're also taking root across the globe, accounting for about &#36;44 billion in crops in five leading countries, according to a report Wednesday by an industry group.
312721
The biotechnology company reported fourth-quarter net income of $201.2 million on strong sales of its two leading drugs, Rituxan and Avonex.
662923
A major expansion is announced for a biotech company based at a former slate quarry.
697697
A takeover attempt follows management shakeups at the biopharmaceutical firm.
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
640990
Now might be a great time to load up on cutting-edge drug makers.
409761
Genzyme shows some sparkle at investors' conference.
301149
Cambridge Antibody Technology&#39;s (Nasdaq: CATG) legal victory over Abbott Laboratories (NYSE: ABT) shows that a biotech David can triumph over a pharmaceutical Goliath.
182389
After a quiet year for biotechnology, a sudden wave of mergers and buyouts has sparked interest in a business that relies on deal-making to put the stamp of success on new ideas.
460518
Science & environment: Research is step towards goal of creating supplies of embryonic stem cells genetically matched to patients